Vycor Medical Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
2,444.50
4,049.70
2,082.60
1,652.30
1,477.00
1,379.40
Depreciation, Depletion & Amortization
376.20
383.00
369.00
267.50
290.00
177.40
Other Funds
676.60
1,566.10
351.90
492.40
499.00
940.90
Funds from Operations
1,391.70
2,100.70
1,361.80
892.40
688.00
261.10
Changes in Working Capital
661.60
600.10
190.20
395.40
160.60
0.80
Net Operating Cash Flow
730.10
2,700.80
1,171.60
496.90
527.40
260.30
Capital Expenditures
194.80
171.10
294.30
57.50
183.30
Net Investing Cash Flow
358.00
171.10
294.30
57.50
183.30
Issuance/Reduction of Debt, Net
756.20
274.40
85.30
266.70
1.50
Net Financing Cash Flow
1,089.10
4,725.60
85.30
266.70
863.90
Net Change in Cash
28.50
1,860.30
1,548.30
290.60
149.40
Free Cash Flow
858.20
2,831.60
1,381.60
554.40
710.70
Net Assets from Acquisitions
163.20
-
-
-
-
Change in Capital Stock
332.80
5,000.00
-
-
862.30
Exchange Rate Effect
29.40
6.60
2.90
3.00
3.80

About Vycor Medical

View Profile
Address
951 Broken Sound Parkway
Boca Raton Florida 33487
United States
Employees -
Website http://www.vycormedical.com
Updated 07/08/2019
Vycor Medical, Inc. engages in the provision of innovative surgical and therapeutic solutions to the medical community. It operates through the Vycor Medical and NovaVision segments. The Vycor Medical focuses on devices for neurosurgery.